China is picking up the fight against rare diseases

Bacteria

(Michael Schiffer, Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Pius Hornstein, General Manager and Country Chair, Sanofi China


“Health is a prerequisite for people’s all-round development and a precondition for economic and social development.” So noted President Xi Jinping in an address to the senior leaders of the Chinese Communist Party in August 2016.

A few months later, with the adoption of the “Healthy China 2030” roadmap by the Chinese government, the country confirmed its ambition to include health in all policies and to link health to economic progress.

“Healthy China 2030” is the most ambitious illustration of China’s efforts to reform its healthcare system. Over the last 20 years, the country made great strides by investing massively in its health facilities and by raising the skills level of its health workers.

But more importantly, China has brought its population close to universal health coverage, thanks to the expansion of government-funded basic medical insurance. This achievement led Dr. Tedros Adhanom, Director-General of the World Health Organization, to acknowledge that the country was “leading by example on universal health coverage.”

Size of the Chinese healthcare market

Dealing with the unique challenges of rare diseases

On the road towards universal health coverage, governments across the world tend to first focus on addressing the most common conditions and primary care, temporarily putting aside those who suffer from rare conditions.

Globally, it is estimated that there are between 5,000 and 8,000 rare diseases. Most of them have a genetic origin and manifest in childhood. They are also often degenerative and life-threatening.

These diseases pose unique challenges to healthcare systems because they require specific medical expertise and significant diagnostic and screening capacities.

More importantly, they also pose unique challenges to patients and their families, who often find themselves isolated and sometimes spend years in search of proper diagnosis.

China’s efforts to prioritize the diagnosis and treatment of rare diseases remained nascent in the first waves of the healthcare system reform and efforts to get to universal coverage. But the need is clear and significant. In a country of around 1.4 billion people, “rare” translates to millions of people who suffer from these diseases. It is estimated that up to 20 million Chinese people suffer from a rare condition.

The government is now keen to catch up and has made rare diseases a public health priority as part of its 2030 roadmap.

In May 2018, the Chinese authorities published a list of rare diseases, covering 121 indications, including multiple sclerosis, Gaucher and Fabry diseases, and haemophilia.

The National Medical Products Administration – China’s pharmaceutical regulator – last year opened the possibility of fast track regulatory review for the registration of certain rare disease medicines.

Looking forward: ensuring that no one is left behind

The importance of rare diseases on the Chinese health and political agenda is growing. The government’s ambition to address rare diseases goes along with China’s new economic development journey, which includes a stronger focus on inclusive and high-quality growth.

In February 2019, Premier Li Keqiang called for further engagement in the fight against rare diseases. As with some cancer medicines the year before, the decision was made to cut the value-added tax rate (from 16% to 3%) for some rare disease medicines, in order to accelerate the launch of new treatments and incentivize their development.

As positive as these developments are, there are still many challenges to overcome to ensure that all Chinese people suffering from a rare disease have access to diagnosis and treatment.

In China and across the world, scarce diagnostic capabilities are one of the main challenges for rare disease patients. Many patients wait years to receive a correct diagnosis.

Ensuring greater knowledge and awareness of rare diseases among healthcare professionals is a basic but fundamental step. Likewise, putting in place early diagnosis and screening schemes can support better identification of patients.

Technology and big data can also be leveraged. Chinese authorities are working to establish databases to better understand the current epidemiology as well as research for future treatments.

Given the scarcity of rare disease patient data, there is the potential to improve the diagnosis and treatment of rare diseases in the near future with an increased use of Real World Evidence. This is derived from observational data obtained outside the context of randomized controlled trials, and the Chinese authorities have recently published draft guidelines for its use.

At the moment, though, several barriers hinder access to already existing treatments. Too many patients face significant out-of-pocket costs that put access to the treatment they need out of their reach. Those who are living in the largest cities of the country can be supported by local funding plans but, at a national level, only partial reimbursement is provided and rare disease treatments have yet to be included in the national drug reimbursement list.

As they work to incentivize the development and registration of medicines addressing rare conditions, establishing a special funding scheme for rare diseases at a national level would enable Chinese authorities to further improve their access and reimbursement policies.

Despite these challenges, it is clear that the recent and positive decisions taken by the government and the increased mobilization of actors in the system – patient groups, physicians, and the pharmaceutical industry – have sparked hope for millions of Chinese patients.

As China’s role and leadership in the global arena increases, other developing countries will be watching to see what can be learned from its approach to helping people suffering from rare diseases, and ensuring that nobody is left behind.

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

Advertising

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

The hidden cost of the electric car boom – child labour

Why this is the year we must take action on mental health

Libya stands at a ‘critical juncture’, UN mission head tells Security Council

4 essential qualities for digital leaders

Five ways to increase trust in e-commerce

This new initiative aims to make cybercrime harder – and riskier – to commit

Greece did it again

ECB bets billions on Eurozone’s economic recovery

UNICEF urges ‘transformative shift’ in family-friendly work policies to reap ‘huge’ benefits

How to make trade single windows more efficient with blockchain

It’s not kids’ screen time you should worry about – it’s yours

Falling inflation urges ECB to introduce growth measures today

As monsoon rains pound Rohingya refugee camps, UN food relief agency steps up aid

Afghanistan: UN mission condemns deadly attack near Kabul airport

The new crisis is already creeping into the financial system

How AI can inspire doctors to be more inventive

Nearly $4 billion needed to protect 41 million children from conflict and disaster

MEPs commend Ukraine‘s reform efforts and denounce Russian aggression

Clean Mobility: Commission tables proposal on car emissions testing in real driving conditions

The end of Spitzenkandidat: EU leaders concluded unexpectedly on EU top jobs

Trump doesn’t only target Germany, aims to crack the entire EU

Britain in chaos: May stays as Tory leader and PM but none can defuse the Brexit time bomb

FROM THE FIELD: Survival in Yemen against all odds

Is the world living up to its climate commitments?

On the detention of children in the United States of America

In wake of ‘collapsed’ agreement, new wave of violence threatens millions in Syria’s Idlib

Draghi drafts a plan to donate more money to bankers, the era of ‘money for nothin’ is flourishing

MWC 2016 LIVE: EC adds Brazil to partner tally

Mental health in medical students: the deciphered quandary

Macron defends the idea of European sovereignty

IMF: Sorry Greece, Ireland, Portugal we were wrong!

Trump’s Russophiles under investigation, Europe remains ‘en garde’

ISIL continues to pose a ‘serious challenge’ worldwide – UN counter-terror chief

Will CETA be implemented after eight long years or it will be vetoed by the EU citizen?

TTIP’s 11th round major takeaways and the usual “leaked” document

Snowden is the “EU nomination” for this year’s Oscars

OECD sees global growth moderating as uncertainties intensify

Country origin ‘best predictor of outcome’ for children with cancer, UN experts say

UNICEF warns of ‘lost generation’ of Rohingya youth, one year after Myanmar exodus

GSMA Mobile 360 – Digital Societies in Kuala Lumpur, in association with The European Sting

Libya: Thousands seek shelter in health clinics from Tripoli fighting, UN warns

From UN Assembly podium, Central African Republic leader appeals for lifting arms embargo

Why the ECB suddenly decided to flood banks with money?

We dream of being a part of the European family, says FYROM PM

‘Virginity testing’: a human rights violation, with no scientific basis – UN

Is Europe ready to cooperate with the rest of the world? Can Germany change its selfish policies?

Scientists can lead the fight against fake news

Monday’s Daily Brief: #ClimateAction for the Pacific, Gaza blockade, attack in Burkina Faso

Eurozone plans return to growth

We have the tools to beat climate change. Now we need to legislate

Global South cooperation ‘vital’ to climate change fight, development, Guterres tells historic Buenos Aires summit

How to future-proof India’s economy

Venezuela: ‘A worrying destabilizing factor in the region’, Bachelet tells Human Rights Council

Guterres condemns killing of Bangladeshi peacekeeper in South Sudan, during armed attack on UN convoy

MEPs back plans to halt spread of drug resistance from animals to humans

Gaza investigators call on Israel to review ‘rules of engagement’ as Gaza protest anniversary looms

Breaking news: Juncker’s Commission mutant trojan horse is on the loose in Strasbourg

4 ways to cyberproof your business during mergers & acquisitions

‘Repeated attacks’ could close down key hospital in eastern Libya, says WHO

Italy’s rescue operation Mare Nostrum shuts down with no real replacement. EU’s Triton instead might put lives at risk

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s